Insider Transactions in Q4 2020 at Cerevel Therapeutics Holdings, Inc. (CERE)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Nov 09 2020	Christopher R Gordon	BUY Open market or private purchase	Indirect	332,293 +0.55%	$3,322,930 $10.3 P/Share
Nov 09 2020	Adam Koppel	BUY Open market or private purchase	Indirect	332,293 +0.55%	$3,322,930 $10.3 P/Share
Nov 09 2020	Bain Capital Investors LLC	BUY Open market or private purchase	Indirect	332,293 +0.55%	$3,322,930 $10.3 P/Share
Oct 27 2020	Christopher R Gordon	BUY Open market or private purchase	Indirect	10,000,000 +14.22%	$100,000,000 $10.0 P/Share
Oct 27 2020	Christopher R Gordon	BUY Other acquisition or disposition	Indirect	49,961,943 +49.83%	-
Oct 27 2020	Adam Koppel	BUY Open market or private purchase	Indirect	10,000,000 +14.22%	$100,000,000 $10.0 P/Share
Oct 27 2020	Adam Koppel	BUY Other acquisition or disposition	Indirect	49,961,943 +49.83%	-
Oct 27 2020	Bain Capital Investors LLC	BUY Open market or private purchase	Indirect	10,000,000 +14.22%	$100,000,000 $10.0 P/Share
Oct 27 2020	Pfizer Inc	BUY Open market or private purchase	Direct	1,200,000 +4.2%	$12,000,000 $10.0 P/Share
Oct 27 2020	Perceptive Advisors LLC Director	BUY Open market or private purchase	Indirect	3,000,000 +48.72%	$30,000,000 $10.0 P/Share
Oct 21 2020	Perceptive Advisors LLC Director	BUY Open market or private purchase	Indirect	43,195 +21.54%	$431,950 $10.09 P/Share
Oct 20 2020	Perceptive Advisors LLC Director	BUY Open market or private purchase	Indirect	114,100 +50.0%	$1,141,000 $10.0 P/Share

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Value

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

Operation

Value

Type

Receive news related to Cerevel Therapeutics Holdings, Inc.